TRACER’s Scientific Advisory Board (SAB) is composed of distinguished Key Opinion Leaders (KOLs) with recognized expertise across early-phase clinical research, clinical imaging techniques, commercial strategy, and pioneering scientific innovation. Our SAB provides strategic guidance, scientific oversight, and expert evaluation to ensure our research and development efforts remain rigorous, forward-looking, and aligned with the evolving needs of patients and the industry.
Supported by high profile Key Opinion Leaders
Ben Feringa (NL)
Professor of Molecular Sciences University of Groningen
Prof. Ben L. Feringa is a Nobel Prize-winning chemist (2016) known for groundbreaking work on molecular motors, switches, and photopharmacology.
Jason Lewis (UK)
Emily Tow Chair Memorial Sloan Kettering Cancer Center
Prof. Jason S. Lewis is a global leader in radiochemistry and molecular imaging. His research focuses on developing radiopharmaceuticals and multimodal imaging agents for clinical translation.
Rudie Dierckx (BE)
Professor Nuclear Medicine University Medical Center Groningen
Prof. Dr. Rudi Dierckx is a nuclear medicine expert with a career divning clinical innovation, academic leadership, and international quality standards. He led departments at UMCG and served as EANM president.
Ian Wilson (UK)
CEO ImaginAb
Dr. Ian Wilson is a biotech leader with 20+ years in radiopharmaceuticals, holding executive roles in global and startup firms including GE Healthcare and Edinburgh Molecular Imaging. He blends scientific expertise with commercialization and strategic leadership in imaging.
Learn more about TRACER’s history and meet the team.
About TRACER
About us
